• 1
    Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Practice & Research in Clinical Obstetrics and Gynaecology, 2006; 20: 207225.
  • 2
    Kagawa-Singer M, Pourat N. Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives. Cancer and Metastasis Reviews, 2001; 89: 696705.
  • 3
    Yi JK. Factors associated with cervical cancer screening behavior among Vietnamese women. Journal of Community Health, 1994; 19: 189200.
  • 4
    Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology, 2000; 151: 11581171.
  • 5
    zur Hausen H. Papillomaviruses in the causation of human cancers – a brief historical account. Virology, 2009; 384: 260265.
  • 6
    Wright TC, Bosch FX, Franco EL et al. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine, 2006; 24 (Suppl 3): S3/251–261.
  • 7
    IARC. European Guidelines for Quality Assurance in Cervical Cancer Screening, 2nd edn. Luxembourg: European Communities, 2008.
  • 8
    Dillner J. Cervical cancer screening in Sweden. European Journal of Cancer, 2000; 36: 22552259.
  • 9
    Gustafsson L, Adami HO. Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. British Journal of Cancer, 1990; 61: 903908.
  • 10
    Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. British Journal of Cancer, 1999; 81: 159166.
  • 11
    Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. British Medical Journal, 2009; 339: b3884.
  • 12
    Taylor VM, Schwartz SM, Jackson JC et al. Cervical cancer screening among Cambodian-American women. Cancer Epidemiology, Biomarkers and Prevention, 1999; 8: 541546.
  • 13
    Green EH, Freund KM, Posner MA, David MM. Pap smear rates among Haitian immigrant women in eastern Massachusetts. Public Health Reports, 2005; 120: 133139.
  • 14
    Pourat N, Kagawa-Singer M, Breen N, Sripipatana A. Access versus acculturation: identifying modifiable factors to promote cancer screening among Asian American women. Medical Care, 2010; 48: 10881096.
  • 15
    Coughlin SS, Richards TB, Nasseri K et al. Cervical cancer incidence in the United States in the US-Mexico border region, 1998–2003. Cancer, 2008; 113 (Suppl 10): 29642973.
  • 16
    Fernandez ME, McCurdy SA, Arvey SR et al. HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethnicity & Health, 2009; 14: 607624.
  • 17
    McMullin JM, De AI, Chavez LR, Hubbell FA. Influence of beliefs about cervical cancer etiology on pap smear use among Latina immigrants. Ethnicity & Health, 2005; 10: 318.
  • 18
    Erwin DO, Trevino M, Saad-Harfouche FG, Rodriguez EM, Gage E, Jandorf L. Contextualizing diversity and culture within cancer control interventions for Latinas: changing interventions, not cultures. Social Science & Medicine, 2010; 71: 693701.
  • 19
    Gregg J, Centurion T, Aguillon R, Maldonado J, Celaya-Alston R. Beliefs about the pap smear among Mexican immigrants. Journal of Immigrant and Minor Health, 2011; 13: 899905.
  • 20
    Marlow LA, Wardle J, Forster AS, Waller J. Ethnic differences in human papillomavirus awareness and vaccine acceptability. Journal of Epidemiology and Community Health, 2009; 63: 10101015.
  • 21
    Bastani R, Glenn BA, Tsui J et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer, Epidemiology & Biomarkers Prevention, 2011; 20: 14631472.
  • 22
    Scarinci IC, Garces-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women's Health (Larchmt), 2007; 16: 12241233.
  • 23
    Perkins RB P-JN, Marquez C, Iloka S, Clark JA. Parents' opinions of mandatory human papillomavirus vaccination: does ethnicity matter. Women's Health Issues, 2010; 20: 420426.
  • 24
    Allen JD, de Jesus M, Mars D, Tom L, Cloutier L, Shelton RC. Decision-Making about the HPV vaccine among ethnically diverse parents: implications for health communications. Journal of Oncology 2012; 2012. doi: 10.1155/2012/401979
  • 25
    Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. Journal of General Internal Medicine, 2003; 18: 10281035.
  • 26
    McPhee SJ, Nguyen TT, Shema SJ et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Preventive Medicine, 2002; 35: 463473.
  • 27
    Miller BA, Chu KC, Hankey BF, Ries LA. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes and Control, 2008; 19: 227256.
  • 28
    WHO/RHR/08.14. WWHO. Cervical cancer, human papillomavirus (HPV) and HPV vaccine. Key points for policy-makers and health professionals. 2008.
  • 29
    Rosenstock IM. The health Belief Model and preventive health behaviour. Health Education Monographs, 1974; 2: 2257.
  • 30
    Statistics Sweden. Swedish for Immigrants, 2009:01:Statistics Sweden, 2009. Available at: (accessed 5 May 2012)
  • 31
    Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research, 4th edn [updated]. Thousand Oaks, CA: Sage Publications, 2009.
  • 32
    Kvale S, Brinkmann S. Den kvalitativa forskningsintervjun. Lund: Studentlitteratur AB, 2009.
  • 33
    OscarssonMG, Wijma BE, Benzein EG. ‘I do not need to… I do not want to… I do not give it priority…’–why women choose not to attend cervical cancer screening. Health Expectations, 2008; 11: 2634.
  • 34
    World Medical Association. Ethical Principles for Medical Research Involving Human Subjects, 2008. Available at: http//, accessed 10 April 2012.
  • 35
    Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 2004; 24: 105112.
  • 36
    Idestrom M, Milsom I, Andersson-Ellstrom A. Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20–59 years. Acta Obstetricia et Gynecologica Scandinavica, 2002; 81: 962967.
  • 37
    Gottvall M, Tyden T, Hoglund AT, Larsson M. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. International Journal of STD & AIDS, 2010; 21: 558562.
  • 38
    Eaker S, Adami HO, Sparen P. Attitudes to screening for cervical cancer: a population-based study in Sweden. Cancer Causes and Control, 2001; 12: 519528.
  • 39
    Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Preventive Medicine, 2001; 32: 482491.
  • 40
    Mortensen GL. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health, 2010; 10: 68.
  • 41
    Williams K, Forster A, Marlow L, Waller J. Attitudes towards human papillomavirus vaccination: a qualitative study of vaccinated and unvaccinated girls aged 17–18 years. Journal of Family Planning and Reproductive Health Care, 2011; 37: 2225.
  • 42
    Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics, 2006; 117: 14861493.
  • 43
    Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Social Science and Medicine, 2009; 69: 475480.
  • 44
    Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Preventive Medicine, 2007; 45: 107114.
  • 45
    Dahlstrom LA, Tran TN, Lundholm C, Young C, Sundstrom K, Sparen P. Attitudes to HPV vaccination among parents of children aged 12–15 years-a population-based survey in Sweden. International Journal of Cancer, 2010; 126: 500507.
  • 46
    Waller J, Marlow LA, Wardle J. Anticipated shame and worry following an abnormal Pap test result: the impact of information about HPV. Preventive Medicine, 2009; 48: 415419.
  • 47
    Blomberg K, Tishelman C, Ternestedt BM, Tornberg S, Leval A, Widmark C. How can young women be encouraged to attend cervical cancer screening? Suggestions from face-to-face and internet focus group discussions with 30-year-old women in Stockholm, Sweden Acta Oncologica, 2011; 50: 112120.
  • 48
    Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database of Systematic Reviews, 2011; 5: CD002834.
  • 49
    Fernandez-Esquer ME, Espinoza P, Ramirez AG, McAlister AL. Repeated Pap smear screening among Mexican-American women. Health Education Research, 2003; 18: 477487.
  • 50
    Wong LP. HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine, 2009; 27: 14101415.
  • 51
    Statistics Sweden. Välfärd 2009:4: Statistics Sweden, 2009. Available at: (accessed 2 June 2012)